FRANKFURT (dpa-AFX Broker) - Driven by takeover fantasies, Evotec shares rebounded from their 2017 low on Thursday morning. The shares of the drug discovery company gained up to 11 percent to 8.17 euros in the MDax after falling to 7.215 euros on Monday. They had thus lost two thirds of their value in 2024.

According to a report by the Bloomberg news agency, this slump in the share price has apparently caused the company to worry about possible takeover bids. The Hamburg-based company has consulted advisors in order to be prepared accordingly, according to sources close to the matter. Several hedge funds have Evotec on their radar, but no one has yet approached the company.

The takeover speculation is now causing problems for speculators who were betting on a further fall in the share price. If they close out their positions, this will create additional buying pressure./ag/tih